Search results
Results from the WOW.Com Content Network
Monoclonal gammopathy of undetermined significance occurs most often in older men. MGUS usually causes no problems. But sometimes it can lead to more-serious diseases.
The most common condition linked with these abnormal proteins is monoclonal gammopathy of undetermined significance (MGUS). It's not cancer. However, people with MGUS may have a greater risk of getting serious diseases of the bone marrow and blood.
Monoclonal gammopathy of undetermined significance (MGUS) When bone marrow produces an unusual protein in the blood, it can sometimes lead to certain types of blood cancer.
Monoclonal gammopathy occurs when plasma cells in the bone marrow produce excessive amounts of monoclonal protein, or M protein. Effects of the condition can range from mild to severe. In some cases, a person can have elevated levels of M protein in their blood without any symptoms.
Monoclonal gammopathy of undetermined significance (MGUS) is a blood disorder that affects plasma cells in your bone marrow. Most of the time, M proteins don’t cause issues and most people with MGUS don’t have symptoms. Some people with this condition may develop a blood cancer or more serious blood disorder.
Monoclonal gammopathy of undetermined significance (MGUS) is, in many ways, a unique hematologic entity. Unlike most hematologic conditions in which the diagnosis is intentional and credited to hematologists, the discovery of MGUS is most often incidental and made by nonhematologists.
Monoclonal gammopathy of undetermined significance (MGUS) patients have no specific treatment, they should undergo detail clinical examination, serum, and urine protein electrophoresis regularly every six to twelve months to look for disease progression.
Researchers at Mayo Clinic coined the term monoclonal gammopathy of undetermined significance (MGUS). They have been studying the disorder for decades. The focus is on finding risk factors for getting the condition, how these risk factors might affect treatment, and how to prevent MGUS from leading to blood cancers and other conditions.
Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from MGUS.
Monoclonal gammopathy of undetermined significance (MGUS) is the production of M-protein by noncancerous plasma cells in the absence of other manifestations typical of multiple myeloma. (See also Overview of Plasma Cell Disorders.)